CONMED Corporation
CNMD
$58.29
-$0.6278-1.07%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.31B | 1.29B | 1.28B | 1.26B | 1.24B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.31B | 1.29B | 1.28B | 1.26B | 1.24B |
| Cost of Revenue | 572.38M | 567.55M | 564.17M | 560.56M | 557.80M |
| Gross Profit | 734.63M | 720.56M | 711.83M | 700.99M | 686.95M |
| SG&A Expenses | 519.27M | 515.94M | 511.30M | 510.38M | 506.12M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.15B | 1.14B | 1.13B | 1.12B | 1.12B |
| Operating Income | 160.93M | 149.35M | 146.34M | 136.95M | 128.22M |
| Income Before Tax | 163.03M | 160.07M | 123.90M | 103.80M | 80.83M |
| Income Tax Expenses | 30.61M | 28.33M | 25.30M | 21.46M | 16.37M |
| Earnings from Continuing Operations | 132.42 | 131.74 | 98.59 | 82.35 | 64.46 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 132.42M | 131.74M | 98.59M | 82.35M | 64.46M |
| EBIT | 160.93M | 149.35M | 146.34M | 136.95M | 128.22M |
| EBITDA | 231.39M | 219.50M | 216.39M | 207.23M | 198.39M |
| EPS Basic | 4.29 | 4.28 | 3.20 | 2.68 | 2.10 |
| Normalized Basic EPS | 2.50 | 2.26 | 2.19 | 1.99 | 1.80 |
| EPS Diluted | 4.24 | 4.21 | 3.14 | 2.61 | 2.04 |
| Normalized Diluted EPS | 2.48 | 2.23 | 2.14 | 1.94 | 1.75 |
| Average Basic Shares Outstanding | 123.37M | 123.21M | 123.09M | 122.94M | 122.67M |
| Average Diluted Shares Outstanding | 124.64M | 124.99M | 125.57M | 126.26M | 126.19M |
| Dividend Per Share | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 |
| Payout Ratio | 18.62% | 18.69% | 24.96% | 29.82% | 38.01% |
